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ObituaryPaul Patterson: In MemoriamCaltech neuroscientist Paul Patterson,
whose career spanned developmental
neurobiology, behavioral neuroscience,
and neuroimmunology, passed away on
June 25th at the age of 70 from an aggres-
sive brain tumor. Patterson was a pioneer
and an iconoclast who was not afraid to
work outside of the scientific mainstream;
consequently, he made a number of
important and seminal contributions
that opened up entire fields of research.
As his colleague of almost 30 years at
Caltech, I watched his scientific evolution
and transformations with curiosity, some
skepticism, and ultimately admiration.
Paul was a consummate scientist, in
the sense that he was consumed with sci-
ence. He was possessed of a restless
imagination and a drive to find hard prob-
lems that others would be too timid or
conservative to investigate. He pursued
these challenges with vigor and passion
to a degree that could strike some as
bordering on the quixotic. Patterson’s
ability to forge his path, without regard
for mainstream opinion, was a continuing
theme throughout his career. In this
respect he was the clear inheritor of the
scientific temperament of his uncle, Clair
Patterson, a professor of geochemistry
at Caltech who pursued a lifelong crusade
to demonstrate the danger posed to
public health by lead poisoning, despite
initial skepticism from his colleagues.
Paul’s friends, students, and close col-
leagues loved him, even as he occasion-
ally exasperated them.
Patterson initially achieved widespread
recognition for his seminal work on the
phenotypic plasticity of neurotransmitter
identity, which he carried out at Harvard
Medical School’s Department of Neuro-
biology in the mid-1970s. He pioneered
methods for the primary culture of
neonatal sympathetic neurons, one of
the first types of isolated neuron
to be grown in vitro. With his student
Linda Chun, and working with Edwin
Furshpan and David Potter, Patterson
demonstrated that immature sympa-
thetic neurons could, when cocultured
with heart cells, switch their neurotrans-
mitter phenotype from noradrenergic to
cholinergic, a switch that was ultimately1040 Neuron 83, September 3, 2014 ª2014 Edemonstrated at the level of single cells
(Patterson et al., 1978). This discovery
was fundamental, as it falsified the
assumption that each class of neuron
was born with an immutable chemical
profile. Importantly, this developmental
plasticity was not a ‘‘tissue culture arti-
fact’’: later work in collaboration with
Harvard colleague Story C. Landis
(currently Director of the NINDS) demon-
strated that sympathetic neurons that
innervate the sweat glands normally
undergo such a switch in transmitter
identity during development in vivo, in a
manner dependent on target-derived
factors (Landis and Keefe, 1983; re-
viewed in Francis and Landis, 1999).
The concept of neurotransmitter pheno-
typic plasticity established by Patterson
and colleagues has stood the test of
time, its lasting significance reinforced
by recent studies demonstrating such
plasticity in the adult nervous system
(Spitzer, 2012).
At the time, these findings had a
broader impact on the field of neural
crest development, as a prominent
example of phenotypic specification by
environmental signals, and they strongly
influenced my own early research
(some of which was performed in close
collaboration with Paul [Anderson et al.,
1991]). They also set the stage for Patter-
son’s decade-long quest to identify the
so-called cholinergic differentiation fac-
tor (CDF), the signal that controls this
transmitter switch. Originally identified
as a bio-activity detected in heart-cell-
conditioned medium (Patterson and
Chun, 1977), CDF was present in vanish-
ingly small quantities. Following Patter-
son’s move to Caltech in 1983, postdoc
Keiko Fukada was able to carry out alsevier Inc.heroic 100,000-fold purification of the
factor.
With the protein in hand, sequence
could be obtained (Yamamori et al.,
1989). I remember walking into Paul’s
office as he was looking at the sequence
of CDF. In a small voice, sounding slightly
puzzled, he asked, (to the best I can recall)
‘‘Do you want to see something really
strange?’’ Astonishingly, the sequence
of CDF revealed that it was identical to
leukemia inhibitory factor (LIF), a cytokine
previously known for its role in the im-
mune system. My impression was that
Paul was surprised because he had ex-
pected that the CDF would be a novel
protein. I don’t know whether or not he
found this disappointing, because Paul
was not one to let his emotions show. In
any case, this finding was a major step
forward and opened the way to identifying
the target-derived CDF in vivo. Further
studies suggested that other ligands of
the LIF coreceptors LIFRß and gp130
were as likely to play this role as LIF itself
(reviewed in Francis and Landis, 1999;
Glebova and Ginty, 2005). In fact, the
in vivo target-derived CDF has yet to be
identified.
At that point, Paul reached an important
crossroads: Should he follow the biology
of the neurotransmitter identity switch
in vivo, identifying and following CDF
even if it was not LIF? Or should he follow
the biology of LIF and related cytokines,
wherever it took him? He chose the latter,
and over the next decade, he investigated
the regulation and function of LIF in many
contexts: neural stem cell self-renewal,
the response to central and peripheral
nerve injury, and inflammatory responses.
This work opened up an entire field of
study of the role of so-called ‘‘neuro-
poietic cytokines’’ in nervous system
development, function, and disease (re-
viewed in Bauer et al., 2007) and marked
the beginning of Patterson’s transforma-
tion from a developmental neurobiologist
to a neuroimmunologist.
It also led to an increasing focus
on the neurobiology of brain disorders
and translational research. Patterson’s
23 years of service on the scientific advi-
sory board of the Hereditary Disease
Neuron
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pursue work on Huntington’s Disease for
over a decade. In this case, he applied
his extensive experience in developing
monoclonal antibodies to neuronal anti-
gens to developing potential ‘‘intrabody’’
therapies for this incurable genetic disor-
der (Khoshnan et al., 2002).
However, it was Patterson’s work on
LIF that led him to become increasingly
interested in understanding the effects of
inflammation on brain development and
neurodevelopmental disorders such as
autism and schizophrenia. He was struck
by epidemiologic studies indicating that
the 1918 influenza epidemic was asso-
ciated with a surge in the incidence
of schizophrenia among children born
during that period. Because respiratory
infections are accompanied by immune
responses that elevate inflammatory
cytokines such as LIF, Patterson began
to investigate the hypothesis that the
maternal inflammatory response to infec-
tion was a major factor in the etiology of
schizophrenia, due its deleterious effects
on the development of the fetal brain.
He established a mouse model of
maternal immune activation (MIA), first
using human influenza virus and then
double-stranded RNA poly (I:C) as a viral
mimetic, and examined the effects of
these treatments on the behavior of the
offspring. In 2003, Patterson published a
seminal paper demonstrating that acti-
vation of the maternal immune system
during pregnancy caused significant
behavioral changes in adult offspring
(Shi et al., 2003). These changes included
deficits in pre-pulse inhibition of the
acoustic startle response, an assay
thought to model cognitive deficits char-
acteristic of autism and schizophrenia.
The offspring also showed increased
sensitivity to antipsychotic drugs such
as chlorpromazine. This study led Patter-
son into a decade-long search to under-
stand the relationship between MIA and
neurodevelopmental disorders (Patter-
son, 2011b).
Patterson’s research into the origins of
autism and schizophrenia characteristi-
cally bucked the trend in the field. At
a time when genomics was yielding
increasing evidence supporting a genetic
origin of these disorders, he continued to
pursue the hypothesis that environmental
influences on fetal brain developmentplayed a significant and perhaps crucial
role. I remember a rather intense ex-
change following a talk by Patterson at a
McKnight Foundation meeting in which a
prominent geneticist bluntly questioned
why anyonewould try to argue for an envi-
ronmental origin of autism when his and
other data so strongly pointed to a genetic
etiology. Paul responded that he was not
denying a role for genetics, but rather
was arguing that environmental factors
were more important than the geneticists
seemed to believe they were. The geneti-
cist was unconvinced. This may (or may
not) have been the first time that Paul
directly faced such trenchant skepticism.
Whatever the case, where others might
have felt cowed or intimidated by such
criticism, Paul stood his ground, and the
debate ended in a standoff.
In light of Paul’s work on phenotypic
plasticity, his focus on environmental
rather than genetic causes of autism and
schizophrenia made perfect sense: it
echoed his earlier emphasis on environ-
mental rather than genetic control of
neural development. He championed the
view that in vertebrates, developing neu-
rons and their precursors were plastic
and that their ultimate phenotype was
more strongly influenced by signals from
their neighbors (the ‘‘American’’ plan)
rather than by their lineage ancestry (the
‘‘European’’ plan), as in invertebrates.
But at a time when genetic determinants
of cell fate in vertebrates were receiving
increasing attention, Patterson eschewed
the cell nucleus and continued to focus
on the role of cell-cell interactions and
other environmental influences on cell
fate.
I havewonderedwhether Paul’s career-
long emphasis on environmental rather
than genetic mechanismswas a reflection
of his scientific background, his style,
or even his politics. His PhD training
with Bill Lennarz at Johns Hopkins
certainly focused him on the cell mem-
brane. At the same time, I had the impres-
sion that, at some level, Paul preferred
to pursue unfashionable approaches
simply to avoid ‘‘doing what everyone
else was doing.’’ And then there was his
inescapable 1960’s persona: the pony
tail, the left-wing politics, the penchant
for Kennedy assassination conspiracy
theories. Paul was at Harvard during the
early 1970’s, when leftist scientists suchNeuron 83, Seas Richard Lewontin and Jon Beckwith
(founder of ‘‘Science for the People’’)
were arguing that espousing genetic
causes of behavioral disorders was inher-
ently reactionary and oppressive (Beck-
with, 2002) and challenging Harvard
geneticist Bernard Davis and sociobiolo-
gist E.O. Wilson in vigorous public de-
bates. Given that influential experience,
I wondered whether his preference for
‘‘nurture’’ over ‘‘nature’’ might, even sub-
consciously, have been in part a reflection
of his political worldview. But this may
well be simply a projection onto Paul of
my own experiences of that time.
While some viewed Paul’s passionate
focus on the MIA hypothesis as tending
toward the fringes, the scientific main-
stream began to take notice as his
research began to provide evidence that
elevated maternal levels of IL-6 during
pregnancy could indeed produce defects
in brain development and behavior in
their offspring. He was invited to write
a Perspective for Science (Patterson,
2007), and his work was even mentioned
in an opinion piece in the New York Times
(Velasquez-Manoff, 2012). Patterson’s
most recent effort to communicate his
viewpoint more broadly was his publica-
tion of a book written for a lay audience,
entitled ‘‘Infectious Behavior: Brain-
Immune Connections in Autism, Schizo-
phrenia and Depression’’ (Patterson,
2011a). The book is not simply an argu-
ment for the maternal inflammation
hypothesis, but features a lively and
entertaining discussion of the general
problem of modeling disorders like
autism and schizophrenia in mice, leav-
ened with the fundamentals of develop-
mental neuroscience. This engaging and
accessible book highlights not only Paul’s
scholarship but also his scientific style
and personality.
Given his tendency to publish his
research in more specialized journals
like Brain, Behavior, and Immunity and
to eschew what British neuroscientist
Jeremy Brockes once trenchantly
described as ‘‘those well-known organs
of spurious glamour,’’ it is ironic that
Patterson’s last publication appeared
inCell. Sarkis Mazmanian, a youngmicro-
biologist at Caltech, engaged Paul and
his graduate student Elaine Hsiao in a
collaboration using the MIA model to
test the idea that alterations in cellularptember 3, 2014 ª2014 Elsevier Inc. 1041
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etiology of neurodevelopmental disorders
(Hsiao et al., 2012). In a follow-up study,
the team demonstrated that offspring
from maternally infected mice exhibited
an altered gastrointestinal microbiome
and leaky gut, associated with increased
circulating levels of potentially neurotoxic
metabolites. Strikingly, both the elevated
levels of these metabolites and autism-
like behavioral phenotypes in these
offspring could be reversed by adminis-
tration of the human commensal gut
microbe Bacteroides fragilis (Hsiao et al.,
2013).
The authors concluded that their results
supported a ‘‘gut-microbiome-brain con-
nection in a mouse model of ASD [Autism
Spectrum Disorder], and identify a poten-
tial probiotic therapy for.human neuro-
developmental disorders.’’ Not surpris-
ingly, the idea that probiotic treatment
could potentially cure autism provoked
an explosion of interest in the popular
media, promptly cited by 27 news outlets.
While Patterson lived to see what was
perhaps the greatest level of media and
mainstream scientific attention to his
work that he had ever experienced in his
career, and felt optimistic and excited
that he was finally on his way out of the
wilderness, as it were, he died before
being able to realize fully the fruits of this
promising line of research.
Paul was as committed to education
and the training of young researchers
as he was to his science. He mentored
scores of graduate students and post-
doctoral fellows, many of whom have
gone on to successful independent
careers in research. His accomplished
laboratory alumnae include former grad-
uate student Allison Doupe, postdoctoral
fellow Louis Reichardt, and many other
notable trainees. Patterson also taught in
the Cold Spring Harbor Neural Develop-
ment course (together with Dale Purves
and Corey Goodman) and several under-
graduate courses at Caltech and directed
the joint Caltech MD-PhD programs with
UCLA and USC. His mentoring style
combined a seriousness of purpose
with a great sense of humor. He was
demanding of his students and impatient
with anything less than a total commit-
ment to science (which he once likened
to ‘‘running a Mom-and-Pop grocery1042 Neuron 83, September 3, 2014 ª2014 Estore: a 16-hour-a-day occupation’’); at
the same time, he hosted countless
parties at his home, with raucous satiric
skits skewering departing laboratory
alumnae. He insisted that guests prepare
and bring exotic dishes, whose compli-
cated recipes he assigned to lab mem-
bers and friends too timid to demur, yet
he reveled in sharing the joys of food
and cooking with his extended scientific
family.
Paul was driven, demanding, stubborn,
inflexible, prickly, and occasionally exas-
perating. He was also warm, generous,
helpful, inclusive, loyal, loving, and often
hilarious. I remember looking down the
hall each morning as I arrived at work,
seeing Paul sitting alone in his spacious
conference room quietly eating his
breakfast cereal under the watchful eyes
of his life-size Marilyn Monroe cutout, his
lab a clear extension of his home. It still
seems impossible to believe, as I walk
down the same corridor and see a locked
door at the end of the hall, that the con-
ference room behind it is now empty,
and the palpable energy and humor that
it once radiated now gone.
Patterson is survived by his wife,
Carolyn, and 14 year-old son, Paul Clair.ACKNOWLEDGMENTS
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